151 related articles for article (PubMed ID: 30554253)
1. MIG Th1 chemokine in Vitiligo.
Elia G
Clin Ter; 2018; 169(6):e303-e307. PubMed ID: 30554253
[TBL] [Abstract][Full Text] [Related]
2. Type 1 diabetes and MIG.
Gonnella D
Clin Ter; 2019; 170(6):e465-e471. PubMed ID: 31696911
[TBL] [Abstract][Full Text] [Related]
3. Sarcoidosis and the Th1 chemokine MIG.
Ragusa F
Clin Ter; 2018; 169(6):e308-e313. PubMed ID: 30554254
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid arthritis and the Th1 chemokine MIG.
Paparo SR
Clin Ter; 2019; 170(6):e472-e477. PubMed ID: 31696912
[TBL] [Abstract][Full Text] [Related]
5. Dermatomyositis and MIG.
Ragusa F
Clin Ter; 2019; 170(2):e142-e147. PubMed ID: 30993311
[TBL] [Abstract][Full Text] [Related]
6. The MIG Chemokine in Inflammatory Myopathies.
Paparo SR
Clin Ter; 2019; 170(1):e55-e60. PubMed ID: 30789198
[TBL] [Abstract][Full Text] [Related]
7. Sarcoidosis and the alpha chemokine MIG.
Giusti C
Clin Ter; 2020; 171(2):e161-e166. PubMed ID: 32141489
[TBL] [Abstract][Full Text] [Related]
8. Sjögren syndrome and MIG.
Ruffilli I
Clin Ter; 2019; 170(6):e478-e482. PubMed ID: 31696913
[TBL] [Abstract][Full Text] [Related]
9. MIG in Cutaneous Systemic Lupus Erythematosus.
Ruffilli I
Clin Ter; 2019; 170(1):e71-e76. PubMed ID: 30789201
[TBL] [Abstract][Full Text] [Related]
10. CXCR3 ligands contribute to Th1-induced inflammation but not to homing of Th1 cells into the lung.
Manicone AM; Burkhart KM; Lu B; Clark JG
Exp Lung Res; 2008 Sep; 34(7):391-407. PubMed ID: 18716926
[TBL] [Abstract][Full Text] [Related]
11. The Th1 chemokine MIG in Graves' ophthalmopathy.
Gonnella D
Clin Ter; 2019; 170(5):e368-e372. PubMed ID: 31612195
[TBL] [Abstract][Full Text] [Related]
12. MIG in autoimmune thyroiditis: review of the literature.
Pezzano M
Clin Ter; 2019; 170(4):e295-e300. PubMed ID: 31304519
[TBL] [Abstract][Full Text] [Related]
13. Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity.
Strassner JP; Rashighi M; Ahmed Refat M; Richmond JM; Harris JE
J Am Acad Dermatol; 2017 May; 76(5):847-855.e5. PubMed ID: 28259440
[TBL] [Abstract][Full Text] [Related]
14. MIG in Crohn's disease.
Caruso C
Clin Ter; 2019; 170(3):e206-e210. PubMed ID: 31173051
[TBL] [Abstract][Full Text] [Related]
15. CXCL9 chemokine in ulcerative colitis.
Elia G; Guglielmi G
Clin Ter; 2018; 169(5):e235-e241. PubMed ID: 30393811
[TBL] [Abstract][Full Text] [Related]
16. The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig.
Piali L; Weber C; LaRosa G; Mackay CR; Springer TA; Clark-Lewis I; Moser B
Eur J Immunol; 1998 Mar; 28(3):961-72. PubMed ID: 9541591
[TBL] [Abstract][Full Text] [Related]
17. MIG chemokine in systemic sclerosis. MIG in Systemic sclerosis.
Ragusa F
Clin Ter; 2018; 169(4):e178-e183. PubMed ID: 30151551
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo.
Wang XX; Wang QQ; Wu JQ; Jiang M; Chen L; Zhang CF; Xiang LH
Br J Dermatol; 2016 Jun; 174(6):1318-26. PubMed ID: 26801009
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of CXCR3-expressing eosinophils and increased concentration of its ligands (IP10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia.
Katoh S; Fukushima K; Matsumoto N; Ehara N; Matsumoto K; Yamauchi A; Hirashima M
Int Arch Allergy Immunol; 2005 Jul; 137(3):229-35. PubMed ID: 15956791
[TBL] [Abstract][Full Text] [Related]
20. Th1 chemokines in ulcerative colitis.
Ragusa F
Clin Ter; 2015; 166(2):e126-31. PubMed ID: 25945446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
